Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women

Nutrition and Cancer

Volumn 63, Issue 3, 2011, Pages 357-366

  Curtin, Karen ^a   Samowitz, Wade S ^b   Ulrich, Cornelia M ^c,d   Wolff, Roger K ^a   Herrick, Jennifer S ^a   Caan, Bette J ^e   Slattery, Martha L ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; CYANOCOBALAMIN; FOLIC ACID; METHIONINE; PYRIDOXINE; RIBOFLAVIN;

ADULT; AGED; ARTICLE; BEAN; CANCER RISK; CARBON METABOLISM; CODON; CONTROLLED STUDY; CPG ISLAND; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; FOOD INTAKE; FRUIT; FRUIT JUICE; GENE; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MTHFR GENE; NUT; RECTUM TUMOR; RISK REDUCTION; SPINACH; TP53 GENE; VEGETABLE; VITAMIN SUPPLEMENTATION;

ADULT; AGED; CASE-CONTROL STUDIES; CPG ISLANDS; DIET; DIETARY SUPPLEMENTS; DNA METHYLATION; FEMALE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; METHIONINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; PHENOTYPE; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECTAL NEOPLASMS; RIBOFLAVIN; RISK FACTORS; SEX FACTORS; TUMOR SUPPRESSOR PROTEIN P53; VITAMIN B 12; VITAMIN B 6;

EID: 79251540715     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2011.535965     Document Type: Article

References (49)

1. Jass JR, Whitehall VL, Young J, and Leggett BA: Emerging concepts in colorectal neoplasia. Gastroenterology 123, 862-876, 2002. (Pubitemid 34977092)
2. Slattery ML, Curtin K, Wolff RK, Boucher KM, Sweeney C, et al.: A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum 52, 1304-1311, 2009.
3. Sweeney C, Boucher KM, Samowitz WS, Wolff RK, Albertsen H, et al.: Oncogenetic tree model of somatic mutations and DNA methylation in colon tumors. Genes Chromosomes Cancer 48, 1-9, 2009.
4. Issa JP, Shen L, and Toyota M: CIMP, at last. Gastroenterology 129, 1121-1124, 2005. (Pubitemid 41242702)
5. Samowitz WS: The CpG island methylator phenotype in colorectal cancer. J Mol Diagn 9, 281-283, 2007.
6. Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, et al.: Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 129, 837-845, 2005. (Pubitemid 41242676)
7. Laird PW and Jaenisch R: The role of DNA methylation in cancer genetics and epigenetics. Ann Rev Genet 30, 441-464, 1996. (Pubitemid 27015267)
8. Nosho K, Irahara N, Shima K, Kure S, Kirkner GJ, et al.: Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS One 3, e3698, 2008.
9. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Meyerhardt JA, et al.: CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 58, 90-96, 2009.
10. Bariol C, Suter C, Cheong K, Ku SL, Meagher A, et al.: The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. Am J Pathol 162, 1361-1371, 2003. (Pubitemid 36350680)
11. Ulrich CM: Nutrigenetics in cancer research - folate metabolism and colorectal cancer. J Nutr 135, 2698-2702, 2005.
12. James SJ, Melnyk S, Pogribna M, Pogribny IP, and Caudill MA: Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr 132, 2361S-2366S, 2002.
13. Kawakami K, Ruszkiewicz A, Bennett G, Moore J, Watanabe G, et al.: The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase. Clin Cancer Res 9, 5860-5865, 2003. (Pubitemid 38018068)
14. Stempak JM, Sohn KJ, Chiang EP, Shane B, and Kim YI: Cell and stage of transformation-specific effects of folate deficiency on methionine cycle intermediates and DNA methylation in an in vitro model. Carcinogenesis 26, 981-990, 2005. (Pubitemid 41214328)
15. Slattery ML, Curtin K, Sweeney C, Levin TR, Potter J, et al.: Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer 120, 656-663, 2007. (Pubitemid 44969038)
16. van Engeland M, Weijenberg MP, Roemen GM, Brink M, de Bruine AP, et al.: Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. Cancer Res 63, 3133-3137, 2003. (Pubitemid 36735864)
17. Iacopetta B, Heyworth J, Girschik J, Grieu F, Clayforth C, et al.: The MTHFR C677T and DeltaDNMT3B C-149T polymorphisms confer different risks for right- and left-sided colorectal cancer. Int J Cancer 125, 84-90, 2009.
18. Mas S, Lafuente MJ, Crescenti A, Trias M, Ballesta A, et al.: Lower specific micronutrient intake in colorectal cancer patients with tumors presenting promoter hypermethylation in p16(INK4a), p4(ARF), and hMLH1. Anticancer Res 27, 1151-1156, 2007. (Pubitemid 46587034)
19. Martinez ME, Maltzman T, Marshall JR, Einspahr J, Reid ME, et al.: Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomas. Cancer Res 59, 5181-5185, 1999. (Pubitemid 29503980)
20. Laso N, Mas S, Jose Lafuente M, Casterad X, Trias M, et al.: Decrease in specific micronutrient intake in colorectal cancer patients with tumors presenting Ki-ras mutation. Anticancer Res 24, 2011-2020, 2004.
21. Schernhammer ES, Ogino S, and Fuchs CS: Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression. Gastroenterology 135, 770-780, 2008.
22. Jacobs ET, Thompson PA, and Martinez ME: Diet, gender, and colorectal neoplasia. J Clin Gastroenterol 41, 731-746, 2007. (Pubitemid 47267759)
23. Slattery ML, Wolff RK, Herrick J, Caan BJ, and Samowitz W: Tumor markers and rectal cancer: support for an inflammation-related pathway. Int J Cancer 125, 1698-1704, 2009.
24. Murtaugh MA, Ma KN, Caan BJ, and Slattery ML: Association of fluids from beverages with risk of rectal cancer. Nutr Cancer 49, 25-31, 2004. (Pubitemid 39299123)
25. Curtin K, Slattery ML, Ulrich CM, Bigler J, Levin TR, et al.: Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis 28, 1672-1679, 2007. (Pubitemid 47303944)
26. Mokarram P, Naghibalhossaini F, Saberi Firoozi M, Hosseini SV, Izadpanah A, et al.: Methylenetetrahydrofolate reductase C677T genotype affects promoter methylation of tumor-specific genes in sporadic colorectal cancer through an interaction with folate/vitamin B12 status. World J Gastroenterol 14, 3662-3671, 2008.
27. Slattery ML, Edwards S, Curtin K, Schaffer D, and Neuhausen S: Associations between smoking, passive smoking, GSTM-1, NAT2, and rectal cancer. Cancer Epidemiol Biomarkers Prev 12, 882-889, 2003. (Pubitemid 37151524)
28. Edwards S, Slattery ML, Mori M, Berry TD, Caan BJ, et al.: Objective system for interviewer performance evaluation for use in epidemiologic studies. Am J Epidemiol 140, 1020-1028, 1994. (Pubitemid 24373007)
29. McDonald A, Van Horn L, Slattery M, Hilner J, Bragg C, et al.: The CARDIA dietary history: development, implementation, and evaluation. J Am Diet Assoc 91, 1104-1112, 1991.
30. Liu K, Slattery M, Jacobs D, Jr., Cutter G, McDonald A, et al.: A study of the reliability and comparative validity of the cardia dietary history. Ethn Dis 4, 15-27, 1994.
31. Slattery ML, Caan BJ, Duncan D, Berry TD, Coates A, et al.: A computerized diet history questionnaire for epidemiologic studies. J Am Diet Assoc 94, 761-766, 1994. (Pubitemid 24226086)
32. Department of Health and Human Services, PHS, Food and Drug Administration: Food standards: amendment of the standards of identity for enriched cereal-grain products to require the addition of folic acid: final rule (21 CFR Parts 136, 137, and 139). Federal Register 61, 8781-8797, 1996.
33. Department of Health and Human Services, PHS, Food and Drug Administration: Food additives permitted for direct addition to food for human consumption: folic acid (folacin): final rule (21 CFR Part 172). Federal Register 61, 8797-8807, 1996.
34. Jacques PF, Selhub J, Bostom AG, Wilson PW, and Rosenberg IH: The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 340, 1449-1454, 1999. (Pubitemid 29220543)
35. Slattery ML, Potter J, Caan B, Edwards S, Coates A, et al.: Energy balance and colon cancer - beyond physical activity. Cancer Res 57, 75-80, 1997. (Pubitemid 27020333)
36. Spirio LN, Samowitz W, Robertson J, Robertson M, Burt RW, et al.: Alleles of APC modulate the frequency and classes of mutations that lead to colon polyps. Nat Genet 20, 385-388, 1998. (Pubitemid 28541640)
37. Curtin K, Samowitz WS, Wolff RK, Caan BJ, Ulrich CM, et al.: MSH6 G39E polymorphism and CpG islandmethylator phenotype in colon cancer. Mol Carcinog 48, 989-994, 2009.
38. Samowitz WS, Albertsen H, Sweeney C, Herrick J, Caan BJ, et al.: Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst 98, 1731-1738, 2006. (Pubitemid 44942711)
39. Burton P, Gurrin L, and Sly P: Extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modeling. Stat Med 17, 1261-1291, 1998. (Pubitemid 28274209)
40. Kuss O and McLerran D: A note on the estimation of the multinomial logistic model with correlated responses in SAS. Comput Methods Programs Biomed 87, 262-269, 2007. (Pubitemid 47212598)
41. Slattery ML, Curtin KP, Edwards SL, and Schaffer DM: Plant foods, fiber, and rectal cancer. Am J Clin Nutr 79, 274-281, 2004. (Pubitemid 41095981)
42. Slattery ML, Kinney AY, and Levin TR: Factors associated with colorectal cancer screening in a population-based study: the impact of gender, health care source, and time. Prev Med 38, 276-283, 2004. (Pubitemid 38177264)
43. Murtaugh MA, Curtin K, Sweeney C, Wolff RK, Holubkov R, et al.: Dietary intake of folate and co-factors in folate metabolism, MTHFR polymorphisms, and reduced rectal cancer. Cancer Causes Control 18, 153-163, 2007.
44. Lee S, Cho NY, Choi M, Yoo EJ, Kim JH, et al.: Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation. Pathol Int 58, 104-113, 2008.
45. Maruti SS, Ulrich CM, and White E: Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. Am J Clin Nutr 89, 624-633, 2009.
46. Kim YI: Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies. Environ Mol Mutagen 44, 10-25, 2004.
47. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, et al.: Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 297, 2351-2359, 2007. (Pubitemid 46883748)
48. Ulrich CM and Potter JD: Folate and cancer-timing is everything. JAMA 297, 2408-2409, 2007.
49. Schernhammer ES, Giovannuccci E, Fuchs CS, and Ogino S: A prospective study of dietary folate and vitamin B and colon cancer according to microsatellite instability and KRAS mutational status. Cancer Epidemiol Biomarkers Prev 17, 2895-2898, 2008.